Index 



305 



Nuclear membrane, electron mircroscop) of, 60 

 in lymphoblasts, li7T> 

 in lymphocytes, 280 

 electron microscopv of, 60 



in inflammation. 75, 70. 78, 80 

 in plasma cell, 28 1 

 in reticulum cell, 263 

 Nucleic acid constituents, reutilization of, 120 

 Nucleolar associated chromatin. 29 

 Feulgen-positive, 34 

 in lymphocytic leukemia, .'51 

 Nucleolus, in lymphoblasts, 275 



leukemic, 27") 

 in lymphocytes, 29, 280 



after adrenalectomy, 114 



electron microscopy of, 56, lio 



in follicular lymphoma, giant, 207 



in lymphoblastic leukemia, 33 

 in lymphoid cells. Feulgen-negative. 34 

 in lymphosarcoma cells, 33 

 in plasma cell. 281 

 in plasmablast, reticular. 28 I 

 in prolymphocytes, 277 

 in proplasmacyte, 284 

 in reticulum cell. 263 



in cat scratch disease. 204 



in Hodgkin's granuloma, 239 



malignant. 268 



sarcomatous, 266 

 Nucleoplasm of lymphocyte, electron micro- 

 scopy of. 56. 60 

 Nncleoproteins of lymphocytes, 34-37 

 desoxypentosenucleic acid (DNA), 34-35 

 pentose nucleic acid (PNA or RNA), 35 

 proteins and amino acids. 37 

 Nucleotidase, in germinal center cells, 12 

 in lymphoid diseases. 198 

 in normal lymphoid elements. 196 

 Nucleus, in lipid histiocyte, 261 

 lobed. See Lohulation of nucleus 

 in lymphoblasts, 275 



leukemic. 27") 

 in lymphocytes, 280 



electron microscopy of. 60-63 



Feulgen reaction. 34 



leukoevtoid, 282 



lohulation alter radiation, 12"). 128. 130. 

 134, 137, 138 



in lymphocytic leukemias, 158 



in malignancies. 281 



radiation affecting. 125, 128, 130, 131. 137. 

 138 



size of, after adrenalectomy, I Hi 



vacuole, intranuclear. 12.">. 130. 134 

 in megakaryocyte, 269 

 in plasma cell. 284 



in lymphocyte formation of, 285 

 in plasmahlast. reticular. 284 

 polynucleosis in Hodgkin's disease. 215 



Nucleus {Continued) 

 in prolymphocytes, 277 

 in reticulum cell, 263 



blood-forming, 270 



in cat scratch disease, 264 



lobulated, in Hodgkin's disease, 239, 246 



leukemic blood-forming, 273 



sarcomatous, L'lili 

 in tumor cells, metastatic, 269 



Oakley, C. 1... 105 

 Oberling, C, 269 



Ocular transplants, of tissue fragments, 105 

 Olson. V. H.. Kit 



Omentum, lymphoid hyperplasia in, after 

 abdominal irradiation. 139 

 tissue fragments transplanted to, 105 

 Opossums, hematopoiesis in, 23 

 Orbit, lymphosarcoma of. 230, 251 

 Organelles, cytoplasmic, in lymphocyte forma- 

 tion of plasma cells, 285 



in plasmahlast. reticular, 284 



in proplasmacyte, 284 

 Origin of lymphocytes, 1-14 

 Osgood, E. E., 69, 212 

 Osteohlasts. in hone marrow, 9 

 Ottesen. J., 279 



Ovary, radiation effects on cells in, 129, 131 

 Oxidase, cytochrome, 45-46 



stains. 203 

 Oxidative activity, enzymes in, 194 



Paff, O. H.. 166 

 Page. A. R., 80 



Palade, small particulate component of, 59 

 Pancytopenia, in Hodgkin's disease, 243, 245, 

 246 

 in lymphatic leukemia, 224 

 in lymphocytic lymphomas, 249, 252 

 in lymphosarcoma, 230 

 Papanicolaou stain, in cell transfer studies, 84 

 Parachromatin, in lymphoblasts, leukemic, 275 

 in lymphocytes. 280 



in inflammation, 75, 80 

 in plasmahlast. reticular. 284 

 in proplasmacyte, 284 

 in reticulum cell. 263 

 blood-forming, 271 

 malignant. 268 

 Paragranuloma, in Hodgkin's disease, 232-236 

 Paratyphoid bacilli injections, and agglutinin 



formation. 105 

 Paresis, lymphocytic infiltrations in. 71 

 Parker. I •'.. 232. 239. 262 

 Parotitis, lymphocytosis in. 149 

 Particulate component of Palade, 59 

 PAS-positive granules, and nadi indophenol 



reaction. 46 

 P \s reaction, and glycogen content, 38 



